HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Minnich, A. Articles by Davignon, J. Search for Related Content PubMed PubMed Citation Articles by Minnich, A. Articles by Davignon, J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 117-124, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent

A Minnich, A Kessling, M Roy, C Giry, G DeLangavant, J Lavigne, S Lussier-Cacan and J Davignon
Clinical Research Institute of Montreal, P.Q., Canada.

It has previously been estimated that due to genetic "founder effects," 97% of lipoprotein lipase (LPL) gene alleles conferring type I hyperlipoproteinemia (HLP) in French Canadians encode one of the following mutant LPL forms: Gly188-->Glu, Pro207-->Leu, or Asp250-- >Asn. Although the genetic basis of type I HLP is known to be homozygosity for LPL deficiency, that for other forms of HLP, especially types IV, and V HLP, is not clear. It is also unclear whether hypertriglyceridemia due to very low density lipoprotein (VLDL) overproduction can be distinguished phenotypically from that due to defective catabolism of plasma lipoprotein triglycerides. The present study took advantage of the unique circumstances inherent in the relatively genetically isolated French Canadian population to address these questions. This study was carried out in order to determine the prevalence of these three mutant LPL alleles, and of a fourth encoding LPL Asn291-->Ser, in French Canadian patients with hypertriglyceridemia. The prevalence of heterozygosity for one of the four LPL mutant alleles in nondiabetic, nonobese hypertriglyceridemic subjects was 16 of 95 type IV HLP (17%) and 4 of 26 type V HLP cases (15%). These alleles were not found in over 150 normotriglyceridemic subjects, supporting the likelihood that the mutant alleles were at least partially responsible for HLP. In addition, heterozygosity for LPL deficiency due to one of these mutations apparently did not contribute to hypoalphalipoproteinemia, and was observed in 3 of 39 subjects with type III HLP. The results suggest that in French Canadians, 15-20% of type IV and V HLP cases are associated with these genetic defects in plasma triglyceride catabolism.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Yang, E. Ruiz-Narvaez, T. Niu, X. Xu, and H. Campos Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica J. Lipid Res., November 1, 2004; 45(11): 2106 - 2109. [Abstract] [Full Text] [PDF]

				References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]

				M. Merkel, R. H. Eckel, and I. J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation J. Lipid Res., December 1, 2002; 43(12): 1997 - 2006. [Abstract] [Full Text] [PDF]

				T. T. Nguyen, K. E. Kruckeberg, J. F. O’Brien, Z.-S. Ji, P. S. Karnes, T. B. Crotty, I. D. Hay, R. W. Mahley, and T. O’Brien Familial Splenomegaly: Macrophage Hypercatabolism of Lipoproteins Associated with Apolipoprotein E Mutation [Apolipoprotein E ({Delta}149 Leu)] J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4354 - 4358. [Abstract] [Full Text]

				B. Hölzl, H. G. Kraft, H. Wiebusch, A. Sandhofer, J. Patsch, F. Sandhofer, and B. Paulweber wo novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers: potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23 J. Lipid Res., May 1, 2000; 41(5): 734 - 741. [Abstract] [Full Text]

				R. Batal, M. Tremblay, L. Krimbou, O. Mamer, J. Davignon, J. Genest Jr, and J. S. Cohn Familial HDL Deficiency Characterized by Hypercatabolism of Mature ApoA-I but Not ProApoA-I Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 655 - 664. [Abstract] [Full Text] [PDF]

				B. G. Nordestgaard, S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjærg-Hansen Heterozygous Lipoprotein Lipase Deficiency : Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease Circulation, September 16, 1997; 96(6): 1737 - 1744. [Abstract] [Full Text]

				C. Sass, L.-M. Giroux, S. Lussier-Cacan, J. Davignon, and A. Minnich Unexpected Consequences of Deletion of the First Two Repeats of the Ligand-binding Domain from the Low Density Lipoprotein Receptor J. Biol. Chem., October 20, 1995; 270(42): 25166 - 25171. [Abstract] [Full Text] [PDF]

				H. Zhang, P. W. A. Reymer, M.-S. Liu, I. J. Forsythe, B. E. Groenemeyer, J. Frohlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma Patients With ApoE3 Deficiency (E2/2, E3/2, and E4/2) Who Manifest With Hyperlipidemia Have Increased Frequency of an Asn 291->Ser Mutation in the Human LPL Gene Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1695 - 1703. [Abstract] [Full Text]